Pharmaceutical
- Pharmaceutical intermediates
- Heterocyclic Compound
- OLED material intermediate
- Diphenylamine intermediates
- Nutritional Supplements
- Pharmaceutical raw materials
Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Urinary System Drugs
- Endocrine System
- Other
Medicine Excipients
Veterinary raw materials
Phone: 86-29-89601602
E-mail: sales21@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
HRK Factory Palmitamide Mea Raw Materials Powder on sale
Product Overview:
Hexadecanamide ethanol (PEA) is an endogenous fatty acid amide that belongs to the class of nuclear factor agonists. It has been shown to bind to receptors in the nucleus of cells (nuclear receptors) and exert a large variety of biological functions related to chronic pain and inflammation.
HRK Factory Palmitamide Mea Raw Materials Powder on sale Attributes
CAS:544-31-0
MF:C18H37NO2
MW:299.49
EINECS:208-867-9
Specification: 99% min Palmitamide Mea Powder
Sample:Palmitamide Mea Powder
Packaging:1kg/bag, 25kg/drum
Brand: Raw Materials
Appearance:white
Storage: Cool Dry Place
Shelf Life: 2 Years
Test Method: HPLC
HRK Factory Palmitamide Mea Raw Materials Powder on sale Details
Palmitamide Mea Usage and Function.
Hexadecanamide ethanol is an organic synthesis intermediate and pharmaceutical intermediate that can be used in laboratory R&D processes and in chemical and pharmaceutical R&D processes.
Uses of Palmitamide Mea.
The main uses of cetamidoethanol include anti-inflammatory and analgesic, enhancement of immunomodulation, treatment of chronic pain, epilepsy, cerebral ischaemia and stroke, Alzheimer's disease and Parkinson's disease. It is also widely used, particularly in sports nutritional supplements and allied health formulations, and these uses reflect the important role of cetamidoethanol in healthcare, especially in the field of naturopathy, where it offers a better alternative as a natural painkiller compared to the possible side effects of conventional medications.
In vitro studies of Palmitamide Mea.
PEA effectively prevented glutamate toxicity in murine cerebellar granule cells and enhanced microglia motility. In mitochondrial fractions from cells stimulated with PEA, the expression of steroid synthesis-rapid regulator protein (StAR) and P450scc, which include some neurosteroid-forming proteins, was increased.PEA also had protective effects: e.g., reduction of malondialdehyde formation in cells treated with L-buthionine-(S,R)-sulfoximine, which is the cause of glutathione deficiency.The effect of PEA was partially mediated by finasteride (5a-reductase inhibitor). The effect of PEA can be partially inhibited by finasteride (5a-reductase inhibitor).
Preparation of Bulk Palmitamide Mea Powder.
